← Back
$XERS All transactions

Xeris Biopharma Holdings, Inc.

▼ SELL 10b5-1 Plan

$ Value

$106K

Shares

15,000

Price

$7

Filed

Dec 15

Insider

Name

BORMANN-KENNEDY BARBARA-JEAN ANNE

Title

CIK

0001635065

Roles

Director

Transaction Details

Transaction Date

2025-12-12

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

142,500

Footnotes

The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.000 to $7.180, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Filing Info

Accession No.

0001635065-25-000004

Form Type

4

Issuer CIK

0001867096

BORMANN-KENNEDY BARBARA-JEAN ANNE's History

Date Ticker Type Value
2025-12-12 XERS $106K
2025-06-04 XERS A $0

Other Insiders at XERS (90d)

Insider Bought Sold Last
Shannon John Patrick Jr
See Remarks
2026-01-31
Hecht Beth
See Remarks
$224K 2026-04-01
Pieper Steven
See Remarks
2026-01-31
Brady James Aloysius $60K 2026-03-30
McCulloch Kevin
See Remarks
2026-01-31
Nguyen Anh Tu
See Remarks
2026-01-30